CalcMyPeptide

GLP-1 Dose Escalation Scheduler

GLP-1 receptor agonists require gradual dose escalation to minimize gastrointestinal side effects. Select your medication below and enter your start date to generate a complete week-by-week schedule with injection dates and syringe units.

Cronograma de Doses GLP-1

GLP-1 RA · Once weekly

Sua Semana AtualMonth 1

0.25mg

Semana 1 · Wegovy

Sem. 1

de 20

Próximo escalonamento: 0.5 mg in 4 semanas (Semana 5)

Cronograma de Escalonamento

0.25 mg
0.5 mg
1 mg
1.7 mg
2.4 mg
Sem. 1Sem. 20
Sem.DataDose
13/24/20260.25 mgVOCÊ
23/31/20260.25 mg
34/7/20260.25 mg
44/14/20260.25 mg
54/21/20260.5 mg
64/28/20260.5 mg
75/5/20260.5 mg
85/12/20260.5 mg
95/19/20261 mg
105/26/20261 mg
116/2/20261 mg
126/9/20261 mg
136/16/20261.7 mg
146/23/20261.7 mg
156/30/20261.7 mg
167/7/20261.7 mg
177/14/20262.4 mg
187/21/20262.4 mg
197/28/20262.4 mg
208/4/20262.4 mg

Fonte: FDA Label (Wegovy) / STEP 1 Trial · Perda de Peso: ~15% · t½: ~7 dias

Supported Protocols

Semaglutide (Wegovy)

GLP-1 Agonist

0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg

Source: FDA Label

Semaglutide (Ozempic)

GLP-1 Agonist

0.25 → 0.5 → 1.0 mg

Source: FDA Label

Tirzepatide (Mounjaro)

Dual GIP/GLP-1

2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg

Source: FDA Label

Retatrutide (Phase II)

Triple Agonist

1 → 2 → 4 → 8 → 12 mg

Source: PMID: 37351564

Explore the Compounds

Dive into detailed profiles covering mechanism of action, clinical trial data, and dosing calculations.

Related Tools